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Abstract
Background: LcrG, a negative regulator of the Yersinia type III secretion apparatus has been
shown to be primarily a cytoplasmic protein, but is secreted at least in Y. pestis. LcrG secretion has
not been functionally analyzed and the relevance of LcrG secretion on LcrG function is unknown.
Results: An LcrG-GAL4AD chimera, originally constructed for two-hybrid analyses to analyze
LcrG protein interactions, appeared to be not secreted but the LcrG-GAL4AD chimera retained
the ability to regulate Yops secretion. This result led to further investigation to determine the
significance of LcrG secretion on LcrG function. Additional analyses including deletion and
substitution mutations of amino acids 2–6 in the N-terminus of LcrG were constructed to analyze
LcrG secretion and LcrG's ability to control secretion. Some changes to the N-terminus of LcrG
were found to not affect LcrG's secretion or LcrG's secretion-controlling activity. However,
substitution of poly-isoleucine in the N-terminus of LcrG did eliminate LcrG secretion but did not
affect LcrG's secretion controlling activity.
Conclusion: These results indicate that secretion of LcrG, while observable and T3SS mediated,
is not relevant for LcrG's ability to control secretion.
Background
Yersinia pestis contains a 75-kilobase (Kb) virulence plas-
mid called pCD1 that encodes the low calcium response
(Lcr) regulon [1]. LcrG is a negative regulator of the Yers-
inia type three-secretion system (T3SS) that is thought to
control secretion of the T3SS-secreted effectors [2], collec-
tively termed Yops [1]. The Yersinia T3SS is activated by
environmental signals [3]; in the presence of calcium,
LcrG blocks secretion from the cytoplasm [4], and in the
absence of calcium, LcrG is primarily located in the
cytosol, with smaller amounts found in association with
membranes and secreted into the culture supernatant [4].
LcrG binds another Yersinia regulatory protein, LcrV, to
unblock secretion via LcrG-LcrV interaction [4]. According
to the LcrG-titration model, in the presence of secretion-
inducing conditions, LcrQ is exported, causing levels of
LcrV to increase relative to the levels of LcrG. The excess
LcrV titrates LcrG and relieves LcrG's secretion-blocking
activity, possibly by removing LcrG from the secretion
complex, which would allow full induction of the LCR
and subsequent secretion of Yops [5,6]. Based on the
LcrG-titration model, LcrG secretion would not be neces-
sary for LcrG function, accordingly this study addresses
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the significance of LcrG secretion to LcrG function in Y.
pestis.
Signals that target Yops to the T3SS apparatus have been
localized to the N-terminus of the Yops and to the mRNA
[7-11]. However, neither the N-terminus of T3S-substrates
nor the mRNA shares a consensus sequence, and the man-
ner in which the T3SS can recognize diverse substrates is
unclear [12-14]. Systematic mutagenesis of the presumed
secretion signal in the N-terminus of YopE yielded
mutants defective in Yop translocation but point mutants
that abolished secretion were not identified [10].
Frameshift mutations that allowed the peptide sequences
of these signals to remain intact also failed to prevent
secretion. Suggesting that the signal that leads to secretion
of Yops appears to be encoded in their mRNA rather than
the peptide sequence [15]. In the case of YopQ, frameshift
mutations were tolerated only when at least 13 codons of
the T3SS signal sequence are present [15]. Mutations in
the second codon of the secretion signal may abolish syn-
thesis of YopQ, and mutations in the tenth codon may
abolish secretion without affecting YopQ's synthesis [15].
In this study, we show that chimeric LcrG proteins with
the GAL4 activation domain (from the GAL4 protein of
Saccharomyces cerevisae [16]) fused to the N-terminus and
the C-terminus of LcrG were not secreted intact. These
non-secreted LcrG-GAL4AD chimeras appeared to trans-
complement a ∆lcrG3 strain of Y. pestis, demonstrating
retention of LcrG function. This result was extended and
confirmed by constructing deletion and substitution
mutations affecting amino acids 2–6 in the N-terminus of
LcrG. None of the LcrG mutants were affected for LcrG
function. However, secretion of some of the functional
mutant LcrGs could not be detected, suggesting that secre-
tion of LcrG is not relevant for known LcrG functions.
Results and Discussion
LcrG was shown to be secreted into the growth medium in
the absence of calcium when lcrG was initially character-
ized in Y. pestis [2]. Interestingly, secretion of LcrG by Y.
enterocolitica is not detected [17]. Secretion of LcrG by Y.
pseudotuberculosis is not examined in the literature, though
secretion of LcrG by Y. pseudotuberculosis IP2666 was not
detectable (data not shown). Reasons for LcrG secretion
in  Y. pestis and not the enteropathogenic yersinae are
unknown and any suggestions at this point would be
purely speculative. The secretion of LcrG by Y. pestis could
possibly relate to the strength of LcrG interaction with
LcrV. However, Lawton et al reported a very strong inter-
action between LcrG and LcrV in Y.pseudotuberculosis when
they characterized residues in LcrV involved in LcrG inter-
action [5] and the LcrG-LcrV interaction has not been
studied in that detail in Y. pestis or  Y. enterocolitica.
Changes in the sequence of LcrG are not likely to account
for the difference in secretion as the Y. pestis and Y. pseudo-
tuberculosis sequences are identical and the Y. enterocolitica
sequences are 96–98% identical, therefore any differences
in LcrG-LcrV interaction would likely be LcrV dependent.
LcrG has been shown to be primarily a cytoplasmic pro-
tein in Y. pestis [4]. However, the exact site of LcrG func-
tion remains to be elucidated. In this study, the ability of
LcrG to function when LcrG secretion was blocked was
examined to test the hypothesis that LcrG secretion may
not be required for LcrG function. In order to determine
the effect of LcrG secretion on LcrG function, LcrG chime-
ras to the GAL4 AD domain and mutants affected in LcrG
secretion were constructed and analyzed for the ability to
regulate Yops secretion, we reasoned that the addition of
GAL4 AD domain should block LcrG secretion. An LcrG
chimera with GAL4AD fused to LcrG's N-terminus
[(GAL4AD-LcrG) constructed for a previous study [18]]
and a new LcrG chimera with GAL4AD fused to LcrG's C-
terminus (LcrG-GAL4AD) were introduced into an lcrG
deletion strain of Y. pestis (∆lcrG3, [19]) and the ability of
the chimeras to regulate Yops secretion and the secretion
of GAL4AD-LcrG and LcrG-GAL4AD, themselves, was
examined. Results demonstrated that both GAL4AD-LcrG
and LcrG-GAL4AD could transcomplement a ∆lcrG3
strain of Y. pestis for growth (data not shown), Yops
expression (Fig. 1A) and Yops secretion (Fig. 1B). Expres-
sion of GAL4AD-LcrG and LcrG-GAL4AD restored Ca2+-
regulation of Yops as evidenced by the Ca2+-regulation of
Yops B, D, E and LcrV (Fig. 1A) in the transcomplemeted
∆lcrG3 strains. The GAL4AD chimera also restored control
of Yops secretion as seen in the silver stained gel of culture
supernatants (Fig. 1B). Both of the chimeric LcrG proteins
were expressed well (Fig. 2A), the GAL4-LcrG appeared to
be degraded to yield free LcrG and the LcrG-GAL4AD had
many degradation products (Fig. 2A), possibly including
free LcrG. Additionally, the LcrG-GAL4AD fusion was
readily secreted (Fig. 2B, lane 10) and the (Fig. 2A)
GAL4AD-LcrG expressing strain appeared to secrete LcrG
(Fig. 2B, lanes 7–8). The generation and secretion of free
LcrG from the LcrG GAL4AD chimeras and the secretion
of the LcrG-GAL4AD chimera limits the ability to draw
conclusions from this set of experiments, since low levels
of LcrG are reported to have observable function [6].
However, these results are suggestive that LcrG may be a
type III secretion substrate and that LcrG secretion may
not be necessary for LcrG function. In addition, the ability
of the LcrG-GAL4AD to be secreted is reminiscent of stud-
ies with YopE fusions that allow secretion of fusion pro-
teins fused to the C-terminus of YopE [20-22].
Because the results with the GAL4AD constructs were not
satisfactory, a second method to disrupt LcrG secretion
was sought to further examine the role of LcrG secretion
on LcrG function. The N-terminus of the Yop effector pro-
teins has been shown to have a signal for secretion in Yers-BMC Microbiology 2008, 8:29 http://www.biomedcentral.com/1471-2180/8/29
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inia [9-11,22,23] and the mRNA of Yops may also serve as
a signal [15,24,25]. Since our LcrG constructs were being
expressed on plasmid constructs separate from native
upstream DNA, the ability of mRNA signals to influence
LcrG secretion was not examined. Accordingly, published
studies on the YopE N-terminal proteinaceous secretion
signal [9-11] were used to guide our mutational manipu-
lation of lcrG  to eliminate LcrG secretion. Plasmids
expressing various mutant LcrG proteins under control of
the araBADp were constructed. The mutant LcrG proteins
comprise; a deletion of aa 2–6 (LcrGd2-6), a replacement
of amino acids 2–6 of LcrG with poly-serine (LcrGpS),
poly-isoleucine (LcrGpI), or an amphipathic sequence
consisting of alternating serine/isoleucine residues
(LcrGpSI). The resulting mutant LcrG constructs express-
ing LcrGd2-6, LcrGpS, LcrGpI or LcrGpSI were trans-
Transcomplementation of Y. pestis ∆lcrG3 with LcrG chimeras and N-terminal LcrG mutants Figure 1
Transcomplementation of Y. pestis ∆lcrG3 with LcrG chimeras and N-terminal LcrG mutants. (A) Immunoblot 
detection of cellular LcrV, YopB, YopD, and YopE. Cells of Y. pestis, wild type (WT) containing plasmid pBAD18 (vector; lanes 
1and 2), Y. pestis ∆LcrG3 containing plasmids pBAD18 (vector; lanes 3 and 4), pAraG18 (LcrG, lanes 5 and 6), pJM174 
(GAL4AD-LcrG; lanes 7 and 8), pLR1 (LcrG-GAL4AD, lanes 9 and 10), pLR2 (LcrGd2-6, lanes 11 and 12), pLR3 (LcrGpS; lanes 
13 and 14), pLR4 (LcrGpI, lanes 15 and 16), pLR5 (LcrGpSI, lanes 17 and 18) were separated by SDS-PAGE in a 10.5–14% gra-
dient, 4–20% gradient or 12.5% polyacrylamide gels and immunoblotted. Immunoblots were probed with α-YopB (12.5% gel), 
α-YopD, α-YopE (10.5–14% gel) and α-LcrV (4–20% gel) primary antibodies. Proteins were visualized with alkaline-phos-
phatase conjugated secondary antibody and developed with NBT-BCIP. (B) Secreted proteins detected by silver staining. Cul-
ture supernatant proteins of Y. pestis; wild type (WT) (vector; lanes 1and 2), Y. pestis ∆LcrG3 containing plasmids pBAD18 
(vector; lanes 3 and 4), pAraG18 (LcrG, lanes 5 and 6), pJM174 (GAL4AD-LcrG; lanes 7 and 8), pLR1 (LcrG-GAL4AD, lanes 9 
and 10), pLR2 (LcrGd2-6, lanes 11 and 12), pLR3 (LcrGpS; lanes 13 and 14), pLR4 (LcrGpI, lanes 15 and 16, pLR5 (LcrGpSI, 
lanes 17 and 18) were separated by SDS-PAGE in a 12.5% polyacrylamide gel and detected by silver staining.BMC Microbiology 2008, 8:29 http://www.biomedcentral.com/1471-2180/8/29
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LcrG secretion and expression by Y. pestis ∆lcrG3 with LcrG chimeras and N-terminal LcrG mutants Figure 2
LcrG secretion and expression by Y. pestis ∆lcrG3 with LcrG chimeras and N-terminal LcrG mutants. Whole cell 
and cell-free culture supernatants were separated by SDS-PAGE in a 4–20% or 10.5–14% gradient polyacrylamide gels. Proteins 
were analyzed by probing with α-LcrG (4–20% gradient polyacrylamide gel) and α-YopN, α-LcrH, α-SycN (10.5–14% gradient 
polyacrylamide gel). Proteins were visualized by probing with alkaline phosphatase conjugated secondary antibodies and devel-
oped with NBT-BCIP. (A) Whole cell fractions, Immunoblots: Lanes 1 and 2 Y. pestis (wild type, WT), Lanes 3 and 4 Y. pestis 
∆lcrG3 pBAD18, Lanes 5 and 6 Y. pestis ∆lcrG3 pAraG18, Lanes 7 and 8, Y. pestis ∆lcrG3 GAL4AD-LcrG, Lanes 9 and 10 Y. pestis 
∆lcrG3 LcrG-GAL4AD, Lanes 11 and 12 Y. pestis ∆lcrG3 LcrGd2-6, Lanes 13 and 14 Y. pestis ∆lcrG3 LcrGpS, Lanes 15 and 16 Y. 
pestis ∆lcrG3 LcrGpI, Lanes 17 and 18 Y. pestis ∆lcrG3 LcrGpSI. Identical immunoblots were prepared and probed separately 
with α-YopN, α-LcrH, α-LcrG or α-SycN, the blots were scanned and strips used to present the data to conserve space. (B) 
Culture supernatants: Lanes 1 and 2 Y. pestis (wild type, WT), Lanes 3 and 4 Y. pestis ∆lcrG3 pBAD18, Lanes 5 and 6 Y. pestis 
∆lcrG3 pAraG18, Lanes 7 and 8, Y. pestis ∆lcrG3 GAL4AD-LcrG, Lanes 9 and 10 Y. pestis ∆lcrG3 LcrG-GAL4AD, Lanes 11 and 
12 Y. pestis ∆lcrG3 LcrGd2-6, Lanes 13 and 14 Y. pestis ∆lcrG3 LcrGpS, Lanes 15 and 16 Y. pestis ∆lcrG3 LcrGpI, Lanes 17 and 18 
Y. pestis ∆lcrG3 LcrGpSI. Identical immunoblots were prepared, one was probed with α-LcrG and the second was sequentially 
probed and developed with α-SycN, then α-LcrH, and finally with α-YopN.BMC Microbiology 2008, 8:29 http://www.biomedcentral.com/1471-2180/8/29
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formed separately into a ∆lcrG3  strain of Y. pestis and
analyzed for LcrG and Yops expression and secretion. Y.
pestis ∆lcrG3 transcomplemented with LcrGd2-6, LcrGpS,
LcrGpI or LcrGpSI expressing plasmids all changed from
calcium blind growth to calcium dependent growth (data
not shown). Importantly, the ∆lcrG3  strain of Y. pestis
transcomplemented with LcrGd2-6, LcrGpS, LcrGpI or
LcrGpSI had restored Ca2+ control of Yops expression (Fig.
1A) and Yops secretion (Fig. 1B) demonstrating LcrG
function by the mutant LcrGd2-6, LcrGpS, LcrGpI and
LcrGpSI proteins. Whole cell lysates from ∆lcrG3 Y. pestis
transcomplemented with LcrGd2-6, LcrGpS, LcrGpI or
LcrGpSI were separated by SDS-PAGE and immunoblot-
ted with LcrG specific antiserum (α-LcrG) to visualize
LcrG expression by the transcomplemented ∆lcrG3 Y. pes-
tis strains (Fig. 2A). ∆lcrG3 Y. pestis strains transcomple-
mented with mutant LcrGs (LcrGd2-6, and LcrGpI)
expressed LcrG at or near wildtype levels (Fig. 2B) demon-
strating stable expression of LcrGd2-6 and LcrGpI. LcrGpS
and LcrGpSI were weakly expressed (Fig. 2A; LcrG is barely
visible in lanes 13, 14, 17 and 18). Immunoblots probed
with α-LcrG from culture supernatants of ∆lcrG3 Y. pestis
grown in the presence or absence of Ca2+ demonstrated
that LcrGpI was not detected in the culture supernatants
(Fig. 2B) (some higher molecular bands are apparent in
lane 16 (Fig. 2B) these are cross-reactive bands from the
LcrV antisera that was used as a secretion control along
with the LcrG antisera) suggesting that LcrGpI was not
secreted. LcrGd2-6 was detected in the culture supernatant
(Fig. 2B) demonstrating that amino acids 2–6 for LcrG are
not required for LcrG secretion. LcrGpS and LcrGpSI were
too weakly expressed for their secretion to be determined
(Fig 2). The LcrG secretion results with LcrGd2-6, LcrGpS,
LcrGpI and LcrGpSI suggest that amino acids 2–6 are not
required for LcrG secretion. However, the composition of
acids 2–6 of LcrG did affect LcrG secretion. Taken
together, results with the LcrG GAL4AD chimeras and the
N-terminal LcrG mutants support the hypothesis that
LcrG secretion is not necessary for LcrG function. The
results with LcrGpI provide the strongest evidence that
LcrG secretion is not required for LcrG function as LcrGpI
is expressed above wildtype levels (Fig. 2A; compare lanes
15–16 with lanes 1–2) and LcrGpI was not secreted unlike
the case of the ∆lcrG3  strain transcomplemented with
LcrG (Fig. 2B) where LcrG is well expressed and easily
detected in culture supernatants. In this manuscript, LcrG
secretion by wildtype Y. pestis was detectable. However,
LcrG secretion has been variably observed [4] and the cur-
rent results are consistent with previous studies on LcrG
function in Y. pestis [2,4,6,18,26]. However, this variable
LcrG secretion does questions whether LcrG is specifically
secreted. To better define if LcrG is specifically secreted the
presence of two known cytosolic proteins were examined.
Whole cell fractions and culture supernatants were probed
with antisera specific for the cytosolic chaperones LcrH
and SycN (Fig. 2). Neither chaperone was secreted (Fig.
2B) consistent with the known behavior of T3SS chaper-
ones. This result confirms that the presence of LcrG in cul-
ture supernatants is likely due to the action of the Yersinia
T3SS and is not due to cell lysis during culture. Addition-
ally the ability of the LcrG-GAL4AD chimera to be
secreted and the disruption of LcrG secretion by mutation
also suggest that LcrG is a T3SS substrate.
The LcrG-GAL4 chimeras and the LcrG mutant proteins
were also tested for the ability to support translocation of
Yops into HeLa cells. Wildtype Y. pestis, ∆lcrG3 Y. pestis
and ∆lcrG3 Y. pestis transcomplemented with GAL4AD-
LcrG, LcrG-Gal4AD, LcrGd2-6, LcrGpS, LcrGpI or LcrGpSI
all were tested for Yops translocation by examining HeLa
cells infected with the various constructs. Infection of
HeLa cells with yersiniae and examination of the cultured
cells for cell 'rounding' has proven to be a very reliable
indicator of Yops translocation [26,27]. The ∆lcrG3 Y. pes-
tis strain transcomplemented with the mutant LcrG pro-
teins (GAL4AD-LcrG, LcrG-Gal4AD, LcrGd2-6, LcrGpS,
LcrGpI and LcrGpSI) or with vector alone were normal for
Yops translocation (Fig. 3) compared to the wildtype Y.
pestis strain (Fig. 3) after 3 h of contact. The ability of the
mutant and chimeric LcrG proteins (GAL4AD-LcrG, LcrG-
Gal4AD, LcrGd2-6, LcrGpS, LcrGpI and LcrGpSI) to sup-
port LcrG function both in vitro and in tissue culture dem-
onstrates that the mutant LcrG proteins are functional to
support Yops secretion regulation and the known
enhancement of Yops translocation by LcrG [19]. Impor-
tantly for this study, mutant and chimeric LcrG proteins
are functional to support Yops secretion and translocation
even though LcrG secretion by ∆lcrG3 Y. pestis strains
transcomplemented with LcrGpI is not observable, sug-
gesting that LcrG secretion is not required to support
translocation. To confirm the results with HeLa cell cyto-
toxicity, the ability of the ∆lcrG3  strains transcomple-
mented with wildtype and mutant LcrG proteins
(GAL4AD-LcrG, LcrG-Gal4AD, LcrGd2-6, LcrGpS, LcrGpI
and LcrGpSI) to translocate YopN was analyzed using a
YopN-GSK construct that is phosphorylated only after
translocation into the eukaryotic cell cytoplasm [28]. All
of the mutant LcrG proteins supported translocation of
YopN-GSK (Fig. 4) demonstrated by the appearance of
PO4-YopN-GSK in the assay. Based on the intensities of
the bands in Fig. 4, no significant differences in transloca-
tion efficiency are apparent.
The results presented in this study demonstrate that LcrG
secretion is signaled at least in part by information in the
N-terminus of LcrG as evidenced by the inability of the
LcrGpI mutant to be secreted. This work is consistent with
the observation of Lloyd et al. that poly-I can block secre-
tion of T3SS substrates in the yersiniae [11]. However,
since the LcrG ∆2–6 mutant could also be secreted, ourBMC Microbiology 2008, 8:29 http://www.biomedcentral.com/1471-2180/8/29
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HeLa cell infections by Y. pestis ∆lcrG3 with LcrG chimeras and N-terminal LcrG mutants Figure 3
HeLa cell infections by Y. pestis ∆lcrG3 with LcrG chimeras and N-terminal LcrG mutants. HeLa cells were 
infected at an MOI of 30. Images were captured 3 hours post infection on an Olympus IX50 inverted microscope fitted with a 
Nikon D70 digital camera (magnification 400×) to document cell cytotoxcity.
Expression and translocation of YopN-GSK Figure 4
Expression and translocation of YopN-GSK. Translocation and phosphorylation of YopN-GSK in infected HeLa cells. 
Infected HeLa cell monolayers were solubilized with SDS-PAGE sample buffer and analyzed by SDS-PAGE in a 12.5% polyacry-
lamide gel and immunoblotted. Immunoblots were probed with phospho-GSK-3β antibodies that detect the GSK tag only 
when phosphorylated and α-YopN antibodies. Proteins were visualized by probing with alkaline phosphatase conjugated sec-
ondary antibodies and developed with NBT-BCIP.BMC Microbiology 2008, 8:29 http://www.biomedcentral.com/1471-2180/8/29
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results suggest that other information is retained in the
LcrG ∆2–6 protein or in lcrG that guides LcrG into the
T3SS. The results presented in this manuscript suggest that
while LcrG is a substrate of the T3SS in Y. pestis, the ability
of LcrG to be secreted by the T3SS is irrelevant to LcrG
function.
Conclusion
In this study, the relevance of LcrG secretion by the Ysc
T3SS was examined. We found that LcrG could function
after construction of LcrG and GAL4AD chimeric proteins,
this was likely due to proteolytic release of LcrG from the
chimera. However, those results prompted a deeper exam-
ination of LcrG secretion by the Ysc T3SS. In agreement
with previous work [2] LcrG was found to be secreted by
the Ysc T3SS in Y. pestis. Subsequent site directed muta-
genesis of the putative T3S-signal in the N-terminus of
LcrG resulted in LcrG mutants that were functional in
Yops-secretion regulation and one stable LcrG mutant
that not was secreted. The discovery of an LcrG mutant
that was functional but not secreted suggests LcrG secre-
tion while mediated by the Ysc T3SS is not necessary for
LcrG function.
Methods
Bacterial strains and plasmids
The bacterial strains used in this study are listed in Table
1. Y. pestis was grown in heart infusion broth (HIB, Difco,
Detroit MI) or on tryptose blood agar base (TBA, Difco)
plates at 26°C for genetic manipulations. Escherichia coli
strains were grown in Luria-Bertani broth (Difco) or on
TBA plates at 37°C. When appropriate, bacteria were
grown in the presence of carbenicillin at a concentration
of 50 µg/ml.
DNA techniques and plasmid constructions
Cloning methods were performed as described previously
[29]. PCR fragments were purified using the QiaQuick
PCR purification kit (Qiagen, Valencia, CA). Transforma-
tion of DNA into E. coli was accomplished by using com-
mercially obtained competent cells (Novablue, Novagen,
Madison, Wis.). Electroporation of DNA into Y. pestis cells
was done as described previously [4]. Gene amplification
was performed with Deep Vent (New England Biolabs,
Beverly, Mass.) or Taq DNA polymerase (Eppendorf Scien-
tific, Westbury, N.Y.). Plasmids used in this study are
described in Table 1. Chimeric LcrG proteins were created
by fusing the GAL4 activation domain (GAL4AD) to the
N- or C-terminus of LcrG [6]. pLR01 (LcrG-Gal4) was con-
structed by amplifying LcrG with primers AraG-start (5'
GGA ATT CAG GAG GAA AGG TCT TCC CAT TTG GAT 3')
and AraG-back (5' CGC GGA TCC AAT ATT TTG CAT CAT
CG 3'). The amplified sequences were digested with EcoRI
and ligated into EcoRI- and SmaI-cleaved pBAD18.
Gal4AD was amplified with primers described by Matson
and Nilles [6]. Plasmids pLR02, pLR03, pLR04 and pLR05
were constructed by performing site-directed mutagenesis
on pAraG18 [26]. Substitution mutations or deletion of
amino acids (aa) 2–6 in the N-terminus of LcrG were con-
structed as indicated in Table 1. Site-directed mutagenesis
was performed with Pfu Turbo DNA polymerase (Strata-
gene, La Jolla, Calif.) using the QuickChange Site-directed
Mutagenesis Kit (Stratagene) according to the manufac-
turer's instructions. Oligonucleotide primers were synthe-
sized by MWG Biotech (High Point, N.C.).
Complementary oligonucleotides were designed to con-
tain the desired mutation, flanked by unmodified
sequence to anneal to the same sequence on opposite
strands of the template plasmid. All mutations were con-
firmed by sequencing.
Table 1: Strains and plasmids used in this study
Strain Relevant properties Source or reference
E. coli Novablue Y. pestis recA1 endA1 hsdR17(rK mK
+) suE44 thi-1 gyrA96 relA1 lac [F'proA+ B+ lacIqZ∆M15::Tn10]N o v a g e n
KIM8-3002 pCD1 (Lcr+) pMT1 Pla- Smr [26]
KIM8-3002.7 KIM8-3002 ∆lcrG3 [LcrG∆6-86]a [19]
Plasmids
pJM174 GAL4(768–881) AD LEU2 LcrG Apr [18]
pBAD18 araBADp cloning vector, Apr [38]
pLR001 LcrG-GAL4(768–881) AD Apr This study
pLR002 pBAD18+lcrG [LcrG∆2–6]a (M ∆2–6 D E) This study
pLR003 pBAD18+lcrG (polyserine aa 2–6)b (M S S S S S D E) This study
pLR004 pBAD18+lcrG (polyisoleucine aa 2–6)b (M I I I I I D E) This study
pLR005 pBAD18+lcrG (polyisoleucine/serine aa 2–6) b (M S I S I S D E) This study
pAraG18 pBAD18+lcrG (wild type) (M K S S H F D E) [26]
aAmino acids deleted are indicated. bAmino acids changed are indicated.BMC Microbiology 2008, 8:29 http://www.biomedcentral.com/1471-2180/8/29
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Media and growth conditions
Plasmids expressing LcrG, LcrG with substitution muta-
tions/deletions of aa 2–6, or the LcrG-GAL4 chimeras
were introduced into the ∆lcrG3 mutant strain
KIM8.3002-7 [19] and cultures were grown in TMH (a
chemically defined medium) [30] with or without cal-
cium. The cultures were shifted to 37°C and arabinose
(0.2% w/v) was added at the same time to induce expres-
sion of LcrG from the vectors. After 4 hours of growth at
37°C, samples from the cultures were harvested and sep-
arated into whole-cell and cell-free culture supernatants as
described previously [4]. Both fractions were analyzed by
immunoblotting to assess protein expression and by
immunoblotting or silver staining (Silver Snap II, Pierce,
Rockford, IL) to assess protein secretion.
Protein electrophoresis and immunodetection
Fractions corresponding to 0.05 A620·ml of bacterial
whole cell or culture supernatants prepared in 2 × SDS-
PAGE sample buffer were loaded for all protein samples.
Proteins were separated by SDS-polyacrylamide gel elec-
trophoresis (SDS-PAGE) according to the method
described by Laemmli [31]. Proteins resolved by SDS-
PAGE were silver stained or transferred to Immobilon-P
membranes (Millipore Corp., Bedford, Mass.) using car-
bonate transfer buffer (pH 9.9) [2] for immunoblotting.
Specific proteins were visualized using rabbit polyclonal
antibodies specific for LcrG (α-LcrG [4]), YopB (α-YopB),
YopD (α-YopD [32]), YopE (α-YopE), LcrV (α-LcrV [4]),
YopN (α-YopN [33]), SycN (α-SycN [34]) and LcrH (α-
LcrH [35]) as primary antibodies and alkaline-phos-
phatase conjugated secondary antibodies followed by
development with 5-bromo-4-chloro-3-indolylphos-
phate/nitroblue tetrazolium NBT-BCIP [36]. Conditions
used for immunodetection were the same for whole cell
and supernatant fractions.
HeLa cell infections
Yop translocation was monitored visually by cytotoxicity
(cells rounding up) with cultured HeLa cells grown in
Dulbecco's Modified Eagle Minimum essential medium
(D-MEM) supplemented with 10% fetal calf serum (FCS,
Invitrogen, Carlsbad, CA), penicillin, pyruvate and
glutamine and grown at 37°C in a 5% CO2 atmosphere.
HeLa cells were seeded into 24-well tissue culture plates
(105 cells/well) and after the HeLa cells reached near con-
fluency the growth medium was removed and the cells
washed twice with L15 medium and placed in L15 for
infection [26]. Next 30 µl of 105 CFU/µL of bacteria were
added (MOI:30). The plates were centrifuged for 5 min-
utes at 25°C (300 × g) to allow cell contact. The plates
were incubated at 37°C for 2–6 hours to check for cyto-
toxicity and photographed at 3 h.
GSK phosphorylation to monitor translocation
Y. pestis strains carrying a pBAD33 derivative expressing
YopN-GSK [28] were pre-induced with L-arabinose (0.2%
w/v) for 1 h prior to infection and 0.2% arabinose (w/v)
was maintained during the infection. HeLa cell monolay-
ers were infected with Y. pestis strains at a multiplicity of
infection (MOI) of 30 for 3 h at 37°C in L15 medium as
described previously [6]. After 3 h, culture supernatants
were decanted and the infected HeLa cells were lysed by
the addition of 100 µl of 2 × SDS-PAGE lysis buffer con-
taining mammalian cell protease (P-8340) and phos-
phatase (P-2850) inhibitor cocktails (Sigma). Samples
were boiled for 5 min and analyzed by SDS-PAGE and
separate identical immunoblots were probed with a GSK-
3β (not shown; no. 9332, Cell Signaling Technology), a
phosphospecific GSK-3β (no. 9336, Cell Signaling Tech-
nology) or an α-YopN antibody preparation. Secondary
antibody (alkaline phosphatase-conjugated anti-rabbit
immunoglobulin G) was diluted in TTBS containing 5%
nonfat milk and 0.05% Tween 20 and incubated with the
blots for 2 h. Blots were washed three times for five min-
utes and developed with BCIP-NBT.
Image acquisition and production
All immnunoblots were scanned on an Epson 4490 Per-
fection scanner at 4800 dpi using VueScan software (v.
8.4.40; Hamrick Software, [37]). Micrographs were cap-
tured on a Nikon D70 digital camera in NEF format. The
scanned blots and micrographs were imported into Adobe
Photoshop (CS3, Adobe Software, San Jose, CA) the
images were converted to grayscale and the auto levels
function was applied. Final figures were assembled in
Adobe Illustrator (CS3) and images were downsampled to
the final resolution upon export to the PNG file format.
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